BackVistra - Warrants (02/02/2024) Overview

Vistra - Warrants (02/02/2024) Operating Income

Latest operating income for VSA: $3.3B.

Get informed when a big investor buys or sells

+ Follow

Quarterly Operating Income

$2.59B
210.31% YoY

As of Sep 30, 2024

Annual Operating Income (TTM)

$3.31B
30.87% YoY

Trailing 12 months ending Sep 30, 2024

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Vistra - Warrants (02/02/2024) (VSA) FAQ

The latest operating income for VSA is $3.3B as of September 2024. That compares with $2.5B in the prior-year period — up 30.9% year over year. Investors often review this figure alongside Vistra - Warrants (02/02/2024)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, VSA's operating income moved from $2.5B to $3.3B — a 30.9% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Vistra - Warrants (02/02/2024)'s operating scale or balance-sheet position.

A operating income figure of $3.3B for VSA is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting VSA's operating income ($3.3B), review year-over-year change from $2.5B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Vistra - Warrants (02/02/2024)'s operating income against similar Utilities names. You can also browse sector and industry screens on Stockcircle for a broader set of Utilities companies and their key multiples and fundamentals.